Financial analysis of Marpai (MRAI) compared to its peers


Marpai (NASDAQ: MRAI – Get Rating) is one of 29 public companies in the “Miscellaneous Health and Related Services, Not Elsewhere Classified” sector, but how does it compare to its peers? We will compare Marpai to similar companies based on the strength of its analyst recommendations, earnings, institutional ownership, profitability, risk, valuation and dividends.

Valuation and benefits

This table compares the gross revenue, earnings per share (EPS), and valuation of Marpai and its peers.

Gross revenue Net revenue Price/earnings ratio
Marpai $14.23 million -$15.98 million -0.60
Marpai Competitors $2.07 billion $88.60 million 6.48

Marpai peers have higher revenue and profit than Marpai. Marpai trades at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Marpai and its peers, as provided by MarketBeat.com.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Marpai 0 0 1 0 3.00
Marpai Competitors 64 336 552 24 2.55

Marpai currently has a consensus price target of $2.50, indicating a potential upside of 190.93%. As a group, companies in the “Miscellaneous Health and Related Services, Not Elsewhere Classified” category have an upside potential of 53.94%. Given Marpai’s stronger consensus rating and higher likely upside, equity research analysts clearly believe Marpai is more favorable than its peers.

Institutional and insider ownership

33.5% of Marpai shares are held by institutional investors. By comparison, 53.2% of the shares of all “Miscellaneous Health and Related Services, Not Elsewhere Classified” companies are held by institutional investors. 41.4% of Marpai shares are held by insiders. By comparison, 25.5% of the shares of all “Miscellaneous Health and Related Services, Not Elsewhere Classified” companies are held by insiders. Strong institutional ownership indicates that large money managers, endowments, and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares the net margins, return on equity and return on assets of Marpai and its peers.

Net margins Return on equity return on assets
Marpai -100.92% -115.72% -61.22%
Marpai Competitors -3,870.67% -105.83% -30.87%

Summary

Marpai’s peers beat Marpai on 7 of the 12 factors compared.

Marpai Company Profile

(Get an assessment)

Marpai, Inc., a technology-driven healthcare payer, is focused on serving the self-insured employer market in the United States and Israel. The Company offers ancillary services, such as care management, case management, actuarial services, administration of health savings accounts and cost containment services. It also develops artificial intelligence and healthcare technology that enables data analysis to predict and prevent events related to misdiagnosis, hospital visits and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.



Get news and reviews for Marpai Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Marpai and related companies with MarketBeat.com’s FREE daily newsletter.


Source link

Comments are closed.